Trading of Polyrizon was halted at 10:35 AM EST due to "LULD pause". Polyrizon (PLRZ) Competitors $1.01 +0.76 (+298.58%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock PLRZ vs. ALBT, AEZS, NLSP, SNGX, ENSC, CPHI, PTN, NKGN, APM, and NCNAShould you be buying Polyrizon stock or one of its competitors? The main competitors of Polyrizon include Avalon GloboCare (ALBT), Aeterna Zentaris (AEZS), NLS Pharmaceutics (NLSP), Soligenix (SNGX), Ensysce Biosciences (ENSC), China Pharma (CPHI), Palatin Technologies (PTN), NKGen Biotech (NKGN), Aptorum Group (APM), and NuCana (NCNA). These companies are all part of the "pharmaceutical products" industry. Polyrizon vs. Avalon GloboCare Aeterna Zentaris NLS Pharmaceutics Soligenix Ensysce Biosciences China Pharma Palatin Technologies NKGen Biotech Aptorum Group NuCana Avalon GloboCare (NASDAQ:ALBT) and Polyrizon (NASDAQ:PLRZ) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership, community ranking and valuation. Is ALBT or PLRZ more profitable? Polyrizon has a net margin of 0.00% compared to Avalon GloboCare's net margin of -1,125.59%. Company Net Margins Return on Equity Return on Assets Avalon GloboCare-1,125.59% N/A -73.69% Polyrizon N/A N/A N/A Does the media prefer ALBT or PLRZ? In the previous week, Polyrizon had 1 more articles in the media than Avalon GloboCare. MarketBeat recorded 4 mentions for Polyrizon and 3 mentions for Avalon GloboCare. Polyrizon's average media sentiment score of 1.06 beat Avalon GloboCare's score of 0.22 indicating that Polyrizon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avalon GloboCare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Polyrizon 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, ALBT or PLRZ? Polyrizon has lower revenue, but higher earnings than Avalon GloboCare. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvalon GloboCare$1.31M4.86-$16.71M-$19.96-0.19PolyrizonN/AN/AN/AN/AN/A Does the MarketBeat Community believe in ALBT or PLRZ? Avalon GloboCare and Polyrizon both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAvalon GloboCareN/AN/APolyrizonN/AN/A Do insiders & institutionals have more ownership in ALBT or PLRZ? 1.4% of Avalon GloboCare shares are owned by institutional investors. 37.3% of Avalon GloboCare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryPolyrizon beats Avalon GloboCare on 4 of the 7 factors compared between the two stocks. Get Polyrizon News Delivered to You Automatically Sign up to receive the latest news and ratings for PLRZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLRZ vs. The Competition Export to ExcelMetricPolyrizonPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.24M$6.84B$5.55B$8.04BDividend YieldN/A2.95%5.09%4.22%P/E RatioN/A7.4422.6818.83Price / SalesN/A257.63404.28106.72Price / CashN/A65.8538.1834.62Price / BookN/A6.576.794.33Net IncomeN/A$143.14M$3.22B$247.97M7 Day Performance197.06%3.59%2.44%2.71%1 Month Performance157.65%6.00%3.78%3.37%1 Year PerformanceN/A-2.03%17.05%5.80% Polyrizon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLRZPolyrizonN/A$1.01+298.6%N/AN/A$4.24MN/A0.00N/ALockup ExpirationPositive NewsGap UpTrading HaltedHigh Trading VolumeALBTAvalon GloboCare1.0845 of 5 stars$3.31+3.4%N/A-11.0%$5.47M$1.31M-0.175Short Interest ↑AEZSAeterna ZentarisN/A$3.04-0.5%N/A-58.7%$5.44M$2.37M-0.2020NLSPNLS PharmaceuticsN/A$1.47+2.9%N/A+1,031.4%$5.29MN/A0.006SNGXSoligenix0.3146 of 5 stars$2.07flatN/A-69.7%$5.20M$840,000.00-0.2720Upcoming EarningsENSCEnsysce Biosciences0.178 of 5 stars$3.67+96.2%N/A-67.4%$5.16M$2.23M-0.1310Upcoming EarningsGap UpHigh Trading VolumeCPHIChina PharmaN/A$1.56-4.6%N/A-93.2%$5.07M$4.53M0.00250PTNPalatin TechnologiesN/A$0.20-7.1%N/AN/A$5.07M$350,000.00-0.1330Gap DownNKGNNKGen BiotechN/A$0.12+9.5%N/A-90.9%$5.03M$80,000.00-0.02N/AGap UpAPMAptorum Group0.9311 of 5 stars$0.96+5.2%N/A-83.3%$4.98M$430,000.000.0030NCNANuCana3.4747 of 5 stars$0.87+11.5%$25.00+2,773.6%-86.9%$4.94MN/A-0.0830Gap Up Related Companies and Tools Related Companies Avalon GloboCare Alternatives Aeterna Zentaris Alternatives NLS Pharmaceutics Alternatives Soligenix Alternatives Ensysce Biosciences Alternatives China Pharma Alternatives Palatin Technologies Alternatives NKGen Biotech Alternatives Aptorum Group Alternatives NuCana Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLRZ) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polyrizon Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Polyrizon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PLRZ Stock Free PLRZ Stock Alerts